Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort
Autor: | Jens Wiltfang, Berend Malchow, Inga Zerr, Niels Hansen, Winfried Stöcker, Charles Timäus |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
medicine.medical_specialty Neurology Neural autoantibodies Pilot Projects Autoimmunity medicine.disease_cause Gastroenterology 03 medical and health sciences 0302 clinical medicine Cerebrospinal fluid Alzheimer Disease Internal medicine Humans Medicine Cognitive Dysfunction ddc:610 Effects of sleep deprivation on cognitive performance Biological Psychiatry Aged Autoantibodies Retrospective Studies business.industry Psychiatry and Preclinical Psychiatric Studies - Original Article Memory clinic Autoantibody Neuropsychology complications [Alzheimer Disease] Psychiatry and Mental health Cognitive impairment 030104 developmental biology Cohort Neurology (clinical) business 030217 neurology & neurosurgery |
Zdroj: | Journal of neural transmission 128(3), 357-369 (2021). doi:10.1007/s00702-021-02316-0 Journal of Neural Transmission |
ISSN: | 1435-1463 0300-9564 |
DOI: | 10.1007/s00702-021-02316-0 |
Popis: | Autoantibody-associated cognitive impairment is an expanding field in geriatric psychiatry. We aim to assess the association between the presence of specific neural autoantibodies and cognitive performance in a memory clinic cohort. 154 patients with cognitive impairment were included between 2019 and 2020 presenting initially in a memory clinic. We evaluated their patient files retrospectively applying epidemiologic parameters, psychopathology, neuropsychology, intracellular and membrane-surface autoantibodies in serum and cerebrospinal fluid (CSF) and markers of neurodegeneration in CSF. In 26 of 154 patients, we searched for neural autoantibodies due to indicators for autoimmunity. In 15/26 (58%) of patients we detected serum and/or CSF autoantibodies. We identified autoantibodies against intracellular or cell-surface antigens in 7 of all 26 (27%) patients with cognitive dysfunction, although we cannot exclude patients with potential specific autoantibodies lacking autoimmune indicators. There were no significant differences between psychopathological and neuropsychological profiles in groups of patients with cognitive impairment comprising patients with autoantibodies (ABS + COG), no autoantibodies (ABS − COG), and Alzheimer’s disease (ADCOG). Concerning our CSF parameters, we detected intrathecal IgG synthesis in 14% of ABS + COG and in 13% of ABS − COG patients, whereas no intrathecal IgG synthesis was found in ADCOG patients. Furthermore, CSF Aß42 was significantly diminished in the ADCOG compared to the ABS + COG group (p p |
Databáze: | OpenAIRE |
Externí odkaz: |